• PSY12 Comparison of the Most Common Reasons for Inpatient Admissions Among Fibromyalgia Patients on Duloxetine Versus Pregabalin

    Nov 1, 2011, 00:00

  • PCV88 Long Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndromes from a Brazilian Public Healthcare perspective Based on Data from the Plato Trial

    Nov 1, 2011, 00:00

  • HS2 Analisis De Costos Del Programa Ampliado De Inmunizaciones En Colombia 2009

    Nov 1, 2011, 00:00

  • PSU5 Risk of Arthritis as A Predictor for the Misdiagnosis of Chondrolysis- An International Analysis of Clinical Outcomes

    Nov 1, 2011, 00:00

  • PHP141 In Search of Reform for the Greek Health Care System- Depicting the Key Opinion Leaders' Views

    Nov 1, 2011, 00:00

  • PRS31 Economic Evaluation of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) from the Public Payer Perspective in Brazil

    Nov 1, 2011, 00:00

  • PRS57 Patient Reported Burden of Asthma Bronchiale in the Slovak Republic

    Nov 1, 2011, 00:00

  • PCN64 Evaluating the Cost-Effectiveness of the Addition of Rituximab to Chemotherapy in the First Line Treatment of Follicular Lymphoma Patients in the UK

    Nov 1, 2011, 00:00

  • PIH5 Replacing MMR By MMRV in Mexico- Assessement of Cost-Effectiveness Based on a Dynamic Transmission Model

    Nov 1, 2011, 00:00

  • PIN38 Guideline Evaluation of Costs Related to Chronic Hepatitis C and Antiviral Treatment Strategies

    Nov 1, 2011, 00:00

  • PCN193 Using Whole Disease Modelling to Inform Economic Recommendations for the Detection, Diagnosis, Treatment and Follow-up of Colorectal Cancer

    Nov 1, 2011, 00:00

  • PSU13 Healthcare Resources Utilization and Associated Costs with Surgical Treatment of Dupuytrenxs Disease in Spain

    Nov 1, 2011, 00:00

  • PHP12 Then and Now- The Evolution of International Reference Pricing Globally

    Nov 1, 2011, 00:00

  • PHP63 Savings on Pharmaceutical Expenditure in Greek NHS Hospitals Under the Shadow of the International Monetary Fund (IMF)

    Nov 1, 2011, 00:00

  • PIN55 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Positive Chronic Hepatitis B in Poland

    Nov 1, 2011, 00:00

  • PRM68 Outcome Measures Hierarchy for Attention-Deficit Hyperactivity Disorder

    Nov 1, 2011, 00:00

  • PND29 Comparing the Cost-Effectiveness of Avonex and Betaferon in the Management of Multiple Sclerosis in Iran

    Nov 1, 2011, 00:00

  • PMS45 Cost-Utility and Budget Impact Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-to-Severe Active Rheumatoid Arthritis in Greece

    Nov 1, 2011, 00:00

  • PRM2 The Reporting of Observational Studies in Spain- Analysis Using the Strobe Statement

    Nov 1, 2011, 00:00

  • PSY17 Retrospective Chart Review Study of the Cost of Care of Systemtic Lupus Erythematousus (Sle) in Five European Countries

    Nov 1, 2011, 00:00

  • PSU3 Prevalence Rates of Surgical Complications Among Tuberous Sclerosis Complex Patients with Surgical Removal of Subependymal Giant Cell Astrocytoma- A Real-World National Retrospective Cohort Study

    Nov 1, 2011, 00:00

  • PCN18 Intermittent Versus Continuous Chemotherapy for First-Line Treatment of Unresectable Metastatic Colorectal Cancer (CCRm)- Systematic Review and Meta-Analysis

    Nov 1, 2011, 00:00

  • PIH42 Patients with Urinary Disorders, Evocative of BPH- What are Their Expectations in France, in Italy and in Portugal?

    Nov 1, 2011, 00:00

  • PHP137 Guidelines for Pharmacoeconomic Evaluation for Serbia

    Nov 1, 2011, 00:00

  • PHP31 The Economic Impact of Switches of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC)- A Systematic Literature Review

    Nov 1, 2011, 00:00

  • PHP111 ISPOR- Awareness, Drivers and Barriers to Involvement of UK Cancer Network Stakeholders

    Nov 1, 2011, 00:00

  • PMS5 analisis De Costo-Efectividad De Agentes Biologicos En El Tratamiento De Pacientes Con Artritis reumatoide Activa Y respuesta insuficiente A Farme Tradicionales Desde La perspectiva Del Sistema Publico De Salud En México

    Nov 1, 2011, 00:00

  • PHP41 Monitoring of HPV Vaccination Effectiveness Within European Union

    Nov 1, 2011, 00:00

  • PCV17 Cost-Effectiveness Analysis of Bosentan and Sildenafil Compared with Standard therapy in Treatment of Primary Pulmonary Arterial Hypertension in Russian Federation

    Nov 1, 2011, 00:00

  • PIN27 Cost analysis of the Consumed Oral Antibiotics in a Tertiary Care

    Nov 1, 2011, 00:00

  • RM2 Aplicacion de Modelos De Regresion Con Stata Para El Estudio Del Consumo de Recursos En Unidades De Cuidados Intensivos Neonatales

    Nov 1, 2011, 00:00

  • PND12 the Cost of Corticosteroid-associated Adverse Events in Systemic Lupus Erythematosus

    Nov 1, 2011, 00:00

  • PIH48 Assessment of Country-Level Health-Related Quality of Life (HRQL) Outcomes and Treatment Effect of Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in Women with Idiopathic Menorrhagia

    Nov 1, 2011, 00:00

  • PCV117 Clinical and Patient-Reported Outcomes of Triple Combination of Olmesartan Medoxomil (OM), Amlodipine Besylate (AML) and Hydrochlorothiazide (HCT) in Hypertensive Patients

    Nov 1, 2011, 00:00

  • PIH49 Otis- An Aid Tool for the Management of Itchy Scalps

    Nov 1, 2011, 00:00

  • PCV68 Pharmacogenomic Testing for Warfarin Use in Typical outpatient Settings Lowers Health Care Costs- The Medco-Mayo Warfarin Effectiveness Study

    Nov 1, 2011, 00:00

  • PMS6 Health Care resource Utilization of Thai Hip Fracture Patients in Public Hospital- Cost of Illness analysis at Chiangrai Hospital

    Nov 1, 2011, 00:00

  • PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in Portugal

    Nov 1, 2011, 00:00

  • PSY50 Managing Pain Management- A Public Health Challenge

    Nov 1, 2011, 00:00

  • PMH74 Impact of Age and Gender in the Pharmaceutical Expenditure of Anxiolytics in Primary Health Care

    Nov 1, 2011, 00:00

  • PCN73 Cost Effectiveness of Zoledronic Acid vs. Pamidronate or No therapy for the Treatment of Bone Metastases Secondary to Prostate Cancer

    Nov 1, 2011, 00:00

  • PRM23 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for Chronic Myeloid Leukaemia

    Nov 1, 2011, 00:00

  • PND39 Hereditary Angioedema Health State Utility Valuation Study from the Perspective of A Representative Sample of the Australian General Public

    Nov 1, 2011, 00:00

  • PSU12 Estimating Cost and Resource Use for Whole Brain Radiation Versus Stereotactic Radiosurgery Treatments Among Brain Metastasis Patients

    Nov 1, 2011, 00:00

  • PRS64 Exploring the Reasons Smokers Dropped Out After Enrolling at the Quit Smoking Clinic (QSC) in Malaysia

    Nov 1, 2011, 00:00

  • PMD44 Economic Evaluation of the UGT1A1 Pharmacogenetic Test to inform Dose Selection of Irinotecan-Based Chemotherapy

    Nov 1, 2011, 00:00

  • PCN184 Trends in Chemotherapy and Biologic Treatment of US Colorectal Cancer Patients

    Nov 1, 2011, 00:00

  • PR4 Analysis of Price Levels of Prescription Drugs and Determinants of international Price Differences between the United States and Selected European Countries

    Nov 1, 2011, 00:00

  • PIH12 Patients with BPH in Fran Results at Six Months with Phytotherapy Versus Other Treatments

    Nov 1, 2011, 00:00

  • PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in Poland

    Nov 1, 2011, 00:00

  • PHP9 Temporary Use Authorizations- The Economic and Clinical Future of Drugs Used in the French Compassionate Program

    Nov 1, 2011, 00:00

  • PHP10 Medication Use Evaluation of Expensive and Broad-Spectrum Antibiotics in Songkhla Hospital

    Nov 1, 2011, 00:00

  • PRM2 EROS- A New Software For Early Stage Of Systematic REVIEWS

    Nov 1, 2011, 00:00

  • PIN33 Economic Impact of the Antiretroviral Pharmacotherapy on Cost and HIV/AIDS Control in Bulgaria

    Nov 1, 2011, 00:00

  • PIN2 Facing Critical Health Events- Economic Impact Of AH1N1 Flu Epidemic In The Mexican Health Sector, 2009-2010

    Nov 1, 2011, 00:00

  • PIN20 Clinical and Economical Impact of Pneumococcal Vaccination in Spanish Adult Population Measured by a Dynamic Model

    Nov 1, 2011, 00:00

  • PRS2 The Role Of RX Data in Comparative Effectiveness Research

    Nov 1, 2011, 00:00

  • PSU15 the Economic Burden of Post-Transplant Events in Renal Transplant Patients in UK, Italy, Netherlands, Poland and Belgium

    Nov 1, 2011, 00:00

  • PMS2 Osteoporosis Medication Might Help reduce the incidence of Second Hip Fractures?

    Nov 1, 2011, 00:00

  • PCV111 Economic Burden and Health- Related Quality of Life in European Patients with Peripheral Arterial Disease

    Nov 1, 2011, 00:00

  • PRS54 Testing of a Conceptual Model of Asthma in Adolescents

    Nov 1, 2011, 00:00

  • PHP42 Calidad De Vida Relacionada Con La Salud Y Apoyo Social En Estudiantes De Farmacia En Venezuela

    Nov 1, 2011, 00:00

  • PHP128 In Depth Analysis of Health Technology Incorporation in Brazil. Is There A Cost-Effectiveness Measure of Threshold?

    Nov 1, 2011, 00:00

  • PMS25 Evaluation of Direct Costs for the Treatment of Active Juvenile Rheumatoid Arthritis Using Biologics

    Nov 1, 2011, 00:00

  • PMH63 Stay Healthy Through Game-Care Therapeutics- It's Time to Play the Game!

    Nov 1, 2011, 00:00

  • PHP105 Cost-Effectiveness in Drug Reimbursement Decision Making- A Toothless Tiger?

    Nov 1, 2011, 00:00

  • PIN12 Analisis De Costo-Efectividad Del Uso De Proteina C Activada (PCA) En Enfermos Con Sepsis Grave Y Choque SÉptico En La Unidad De Cuidados Intensivos Del Hospital Regional 1° De Octubre Del ISSSTE

    Nov 1, 2011, 00:00

  • PDB11 Glycemic Outcomes Among Patients Receiving Exenatide BID or Liraglutide for Type 2 Diabetes in Clinical Practi A Retrospective Analysis of the GE Centricity EMR Data

    Nov 1, 2011, 00:00

  • PHP77 Exploring Different HRQOL Measures as Predictors of Future Health Care Expenditures

    Nov 1, 2011, 00:00

  • PIN62 A Multidisciplinary Support program in Hepatitis C Treatment- An Economic Evaluation

    Nov 1, 2011, 00:00

  • PSS19 Glaucoma Management Cost as A Function of Disease Stage and Treatment Changes

    Nov 1, 2011, 00:00

  • PMS47 The Long Term Cost-Effectiveness of Golimumab for the Treatment of Severe, Active Ankylosing Spondylitis in Adults Who Have Responded Inadequately to Conventional Therapy

    Nov 1, 2011, 00:00

  • PRM41 are General Population Data Suitable for Approximating Baseline Utility Values in Economic Models?

    Nov 1, 2011, 00:00

  • PDB80 Validation of the Updated Charlson Comorbidity Index (CCI) for Use in Patients with Diabetes or Asthma- A Comparison Study

    Nov 1, 2011, 00:00

  • PRM57 Revisiting HPV Vaccination- Why Existing CEAs Underestimate the Vaccine'S Cost-Effectiveness and Incorrectly Estimate Its Threshold Price

    Nov 1, 2011, 00:00

  • PMH6 Effectiveness of Long-Acting Iinjectable Risperidone and Oral Atypical Antipsychotics in a 24-Months Observational Study in Adult Patients with Schizophrenia in Germany

    Nov 1, 2011, 00:00

  • PMS2 Risk and Cost of Infections in Rheumatoid Arthritis Patients Treated with anti-TNF therapy in Alberta, Canada

    Nov 1, 2011, 00:00

  • PDB61 Assessment of Quality of Life in Children and Adolescents with Type 1 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PRS45 Fully Incremental Cost-Effectiveness Analysis of Available Treatment Options in the Management of Severe COPD in the UK Setting

    Nov 1, 2011, 00:00

  • PCN181 The Health Related Quality of Life Data (HRQoL) for Health Technology Assessment (HTA) Process in Europe- Their Utilization and Impact on Opinions across HTA Agencies

    Nov 1, 2011, 00:00

  • PCN50 First and Second Line Lung Cancer Treatment Utilization Patterns and associated Costs in A United States Health Care Claims Database

    Nov 1, 2011, 00:00

  • PCV37 Parametric Conditional Non-Frailty Model for Recurrent Events in Persons with Type 2 Diabetes in Sweden- The Example of Myocardial Infarction

    Nov 1, 2011, 00:00

  • PHP10 Two Phases Study on the Perspective of Health Care Professionals on Current Mechanisms for Authorizing the Prescription of Specifically Controlled Medicines in Spain

    Nov 1, 2011, 00:00

  • PCV124 Reference Pricing, Originator Drugs and Consumerxs Choice

    Nov 1, 2011, 00:00

  • PMD69 Treatment of Urinary Tract infections is Common amongst Swedish Patients in Need of Chronic Catheterisation

    Nov 1, 2011, 00:00

  • PHP120 The Past As Prologue- Use of Comparative Effectiveness Reviews (CER) in National Coverage Decision Making by Medicare in the United States and Predictions on Future Use of CER

    Nov 1, 2011, 00:00

  • PSY49 Pain Management- Impact on Quality of Life

    Nov 1, 2011, 00:00

  • PND49 Initial Psychometric Properties of the Eurodolmed Questionnaire- A New Instrument to Measure Neuropathic Pain in Patients with Spinal Cord Injury (SCI) Based on Pain Intensity, Pain Interference and Pain Descriptors

    Nov 1, 2011, 00:00

  • PRS66 Drug Use Review in Patients with Bronchial Asthma - the Introduction of the Optimization Program of Therapy

    Nov 1, 2011, 00:00

  • PIN106 HIV Screening Programme in Community Pharmacies of the Basque Country

    Nov 1, 2011, 00:00

  • PCV7 Tobacco Addiction Influence in Later Development of Cardiovascular Events- 3 Years Follow-up

    Nov 1, 2011, 00:00

  • PND64 Cost-Minimization Analysis of IFNB-1B and Fingolimod among Multiple Sclerosis Patients in Germany

    Nov 1, 2011, 00:00

  • PRM36 Comparing the Performance of the SF-6D and EQ-5D Across Diseases

    Nov 1, 2011, 00:00

  • PCV9 Optimal Treatment Shortfalls and Worse 12-Month Outcomes for Diabetic Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention in Contemporary Practi Data from the Multinational, Prospective, Antiplatelet Treatment Out ...

    Nov 1, 2011, 00:00

  • IN1 Evaluacion De COSTO-Efectividad Con El Uso De Linezolid Para El Tratamiento De Infecciones Complicadas De Piel Y Tejidos Blandos

    Nov 1, 2011, 00:00

  • PMH53 Follow-up of Health-Related Quality of Life in Young Heroin Users

    Nov 1, 2011, 00:00

  • PDB25 Real-World Outcomes of Initiating Two Different Basal Insulin Therapies Via Disposable Pens Among Patients with Type 2 Diabetes in US Employer-Sponsored Health Plans

    Nov 1, 2011, 00:00

  • PCN104 Cost Minimization Analysis (CMA) of Capecitabine/Cisplatin (XP) vs. 5-Fu/Cisplatin (FP) Regimens in Advanced Gastric Cancer (AGC) Treatment in the Romanian Setting

    Nov 1, 2011, 00:00

  • PHP103 Global Health Care Reforms and Pricing, Access and Health Outcomes Strategy

    Nov 1, 2011, 00:00

  • PDB55 Translation and Validation Study of 14-Item Michigan Diabetes Knowledge Test (MDKT)- The Urdu Version

    Nov 1, 2011, 00:00

  • PDB15 Use of Hypoglicemic Drugs in Serbia- Pharmacotherapeutic Versus Pharmacoeconomic Aspects

    Nov 1, 2011, 00:00

  • PRM58 Methodological Reviews of Economic Evaluations in Health Care- Are They Useful?

    Nov 1, 2011, 00:00

  • PCN129 Mapping the Cancer-Specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the Generic EQ-5D in Metastatic Breast Cancer Patients

    Nov 1, 2011, 00:00

  • PMH65 The Challenge of Adherence and Individualized Treatment in Severe Mental Disorders – A Nordic Perspective

    Nov 1, 2011, 00:00

  • PCV4 Comparative Efficacy of Maintenance of Sinus Rhythm Versus Rate Control Strategies in the Treatment of Atrial Fibrillation – Systematic Review and Meta-Analyses

    Nov 1, 2011, 00:00

  • PDB37 Injection of Long-Acting Somatostatin Analogs- A Cost Consequence Analysis for Three European Countries

    Nov 1, 2011, 00:00

  • PND37 An Examination of Resource Utilization Among Patients with Parkinson'S Disease Treated with Rasagiline or Selegiline

    Nov 1, 2011, 00:00

  • PCN58 The Cost of Strong Opioid Treatment of Oncological Pain in the Brazilian Private Health Care System

    Nov 1, 2011, 00:00

  • PMD63 Cost-Benefit analysis of CT Contrast Media (Iopromide) with Prefilled Cartridge Type Compared to Glass Bottle Type

    Nov 1, 2011, 00:00

  • PMH40 Economic Evaluation of Agomelatine for Major Depressive Disorder in Australia

    Nov 1, 2011, 00:00

  • PIH1 Impacto Presupuestal Del Uso De Levonorgestrel-Uis Frente A Otros Tratamientos En Menorragia Idiopatica En Colombia

    Nov 1, 2011, 00:00

  • PMD62 Validation of A Patient-Reported Outcome (PRO) Measure and A Clinician-Reported Outcome (CRO) Measure to assess Satisfaction and Preference with Pharmacological Stress Agents for Single Photon Emission Computed tomography (SPECT) Myoc ...

    Nov 1, 2011, 00:00

  • PIN11 The Impact of Directly Observed Therapy (DOT) in Patients with Tuberculosis

    Nov 1, 2011, 00:00

  • PDB33 Cost of Diabetes Management to Cocoa Clinics in Ghana

    Nov 1, 2011, 00:00

  • PCV113 Patient Satisfaction with Stroke Prevention in Atrial Fibrillation – Medical-Driven Interim Results of a European Survey

    Nov 1, 2011, 00:00

  • PMS16 Potential Cost Saving of Epoetin Alfa Compared to Autologous Blood Donation or to No-Blood-Conservation-Strategy Before Elective Hip or Knee Surgery Due to reduction in Allogeneic Blood Transfusions and Its Side Effects

    Nov 1, 2011, 00:00

  • PUK13 Prevention in Predialitic Stage has Better Results in Health

    Nov 1, 2011, 00:00

  • PCN43 Cost of HPV Associated Diseases in Saint-Petersburg

    Nov 1, 2011, 00:00

  • PCN93 Cost-Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer- A Systematic Review

    Nov 1, 2011, 00:00

  • PRM69 Measuring Relative Effectiveness in Europe- As in the USA, Here Too, It is Time to Turn the QALY Page

    Nov 1, 2011, 00:00

  • PSS31 Association Between Eq-5D and Dermatology Life Quality Index (Dlqi) in Patients With Chronic Hand Eczema

    Nov 1, 2011, 00:00

  • PMH13 Differences Between Patients Undergoing Augmentation or Switching of Antipsychotic Medications During Treatment of Schizophrenia

    Nov 1, 2011, 00:00

  • PIN84 Lost in Translation- A Markov Model Cost Utility Analysis of Lopinavir/Ritonavir Vs Atazanavir + Ritonavir

    Nov 1, 2011, 00:00

  • PRS9 Disponibilidad A Pagar Por Un Metodo Efectivo Para Dejar De Fumar- Evidencias A Partir De La Encuesta Global De Tabaquismo En Adultos MÉxico 2009

    Nov 1, 2011, 00:00

  • PMS52 Additional Medical Costs Due to Falls/Slips at Three Teaching Hospitals in Japan

    Nov 1, 2011, 00:00

  • PDB27 Projected Cost-Effectiveness of Exenatide Once Weekly Versus Exenatide Bid for the Treatment of Type 2 Diabetes in the UK

    Nov 1, 2011, 00:00

  • PHP157 Using the CEAC for Value Based Pricing- Don'T Change the Goalposts

    Nov 1, 2011, 00:00

  • PIN10 Exchange Rate Or Power Purchase Parity For Economic Evaluation- Estimating The Costs Of Rotavirus Vaccination In A Six-Year Period Considering Data From Mexican Children

    Nov 1, 2011, 00:00

  • PRS47 Optima Model-Based Cost-Utility Analysis of Fixed Combination Salmeterol/Fluticasone Versus Non-Fixed Combination Budesonide/Formoterol in One Pack for Bronchial Asthma Treatment

    Nov 1, 2011, 00:00

  • PCV109 Measuring Health Utility in Thai Stroke Patients

    Nov 1, 2011, 00:00

  • PHP8 Measuring Adherence to Drug Treatment in Mexican Patients- A Systematic Review

    Nov 1, 2011, 00:00

  • IN4 Morbidity and Mortality of Community Acquired Pneumonia in Adults in Six Countries in Latin America

    Nov 1, 2011, 00:00

  • PRS49 Economic Burden Attributable to Obesity in Adult Patients with Asthma in the United States

    Nov 1, 2011, 00:00

  • PMS33 Economic Evaluation of intravenously Ibandronate for the Treatment of Postmenopausal Osteoporosis in Mexico

    Nov 1, 2011, 00:00

  • PRM20 Comparison of Three Methods for Measuring Multi-Morbidity According to the Use of Health Resources in Primary Health Care

    Nov 1, 2011, 00:00

  • PND8 Prevalence and Procedure for Vertigo Follow-up in France

    Nov 1, 2011, 00:00

  • PCV29 Recent In-Hospital Mortality Trends Among Patients with Heart Failure in the Netherlands

    Nov 1, 2011, 00:00

  • CN3 Validation Study Of The Baseline Quality Of Life As A Prognostic Indicator Of SURVIVAL- A Pooled Analysis Of Individual Patient Data From NCIC Clinical Trials

    Nov 1, 2011, 00:00

  • PRS53 Further Developments of the Asthma Life Impact Scale (ALIS)

    Nov 1, 2011, 00:00

  • PRM54 Model and Covariate Visualization Aids for Enhancing the Interpretation of Steps in the High Dimensional Propensity Scoring Adjustment Procedure

    Nov 1, 2011, 00:00

  • PCN33 Cost Analysis- Treatment of Chemotherapy-Induced Anaemia with Erythropoiesis-Stimulating Agents (ESAs) in Spain

    Nov 1, 2011, 00:00

  • PND43 Validation of the Self Assessment of Treatment (SAT) Questionnaire

    Nov 1, 2011, 00:00

  • PIN48 Cost-Effectiveness of a Pentavalent Human-Bovine Reassortant Rotavirus Vaccine (RV5) in Japan

    Nov 1, 2011, 00:00

  • PDB74 Title- Implementation of Diabetes Programme Budget Marginal Analysis (PBMA) Exercise in an English Primary Care Trust (PCT)

    Nov 1, 2011, 00:00

  • PHP54 Predictors of Avoidable Emergency Room Visits Among High Cost Medicaid Enrollees

    Nov 1, 2011, 00:00

  • PHP73 Government Reduces Public Pharmaceutical Expenditure in Hungary- Rational Decisions in Challenging Economic times?

    Nov 1, 2011, 00:00

  • PRM40 Improving the Measurement of quality of Life Based on Fuzzy Scale

    Nov 1, 2011, 00:00

  • PHP39 Toward a Better Drug Pricing Policy in Korea- Links Between Price Regulation and RD Activities

    Nov 1, 2011, 00:00

  • PCV5 Thromboembolisms with Thrombopoietin Receptor Agonists- Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2011, 00:00

  • PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained Resources

    Nov 1, 2011, 00:00

  • PGI4 Cost-Effectiveness of Esomeprazole Versus Pantoprazole in Acute and Maintenance Treatments of Reflux Esophagitis in Turkey

    Nov 1, 2011, 00:00

  • PSY36 Modelling the Cost-Effectiveness of Orlistat as a Treatment for Obesity in Primary Care

    Nov 1, 2011, 00:00

  • PCV38 Budget Impact of Changing Future Statin Use Patterns in Sweden

    Nov 1, 2011, 00:00

  • PMH5 Analisis De Costo Efectividad Del Manejo Farmacologico De La Esquizofrenia Recurrente En Peru Ajustado Por La Adherencia Ai Tratamiento

    Nov 1, 2011, 00:00

  • PHP165 A New Anti-Rebate Legislation in South Korea- Will It Work This Time?

    Nov 1, 2011, 00:00

  • PND50 Public Preferences for the Predictive Genetic Test for Alzheimer'S Disease in the United States

    Nov 1, 2011, 00:00

  • PIH30 Endometriosis-Associated Pelvic Pain Treated with Dienogest or GNRH Analogues- Cost-Utility Comparison with 5 Years Time Horizon

    Nov 1, 2011, 00:00

  • PDB22 ‘Real-World' Clinical Outcomes of Exenatide Bid Compared to Insulin Glargine in Patients with Type 2 Diabetes

    Nov 1, 2011, 00:00

  • PHP99 Reimbursing Telemonitoring in Europe- Are Payers Ready?

    Nov 1, 2011, 00:00

  • PRS38 The Cost-Effectiveness of Roflumilast for COPD in Sweden

    Nov 1, 2011, 00:00

  • PSU4 Postoperative Prevalence Rate of Subependymal Giant Cell Astrocytoma (SEGA) Diagnosis and Repeated Sega Surgery in Patients with Tuberous Sclerosis Complex- A Real-World National Retrospective Cohort Study

    Nov 1, 2011, 00:00

  • PND7 Disability Progression in Patients with Relapsing Remitting Multiple Sclerosis (RRMS) Who Experience Disease Activity Despite Previous Disease Modifying Therapy

    Nov 1, 2011, 00:00

  • PHP122 A Comparison of HTA Recommendations Issued by Agency for Health Technology Assessment in Poland (AHTAPol) and National Institute for Health and Clinical Excellence (NICE) in the UK – Consideration of Social Implications in HTA

    Nov 1, 2011, 00:00

  • PDB58 How Much Do Patients with Type 2 Diabetes Value Improvements in Dosing Convenience? Results from a Conjoint Study

    Nov 1, 2011, 00:00

  • PRM13 Assessing the Methods for Systematic Reviews of Economic Evaluations

    Nov 1, 2011, 00:00

  • PCN20 Systematic Review of Skeletal Related Events in Breast Cancer

    Nov 1, 2011, 00:00

  • PMH59 Employment Status and Self reported Quality of Life in Chinese Patients Receiving Treatment for Major Depressive Disorder

    Nov 1, 2011, 00:00

  • PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in Canada

    Nov 1, 2011, 00:00

  • AD4 Health Outcomes as a Function of Intentional and Unintentional Non-Adherence Among Eleven Costly Conditions in the EU

    Nov 1, 2011, 00:00

  • PGI5 Irritable Bowel Syndrome with Constipation (IBS-C)- A European-Focused Systematic Literature Review of Disease Burden

    Nov 1, 2011, 00:00

  • PMS11 review of the Studies on Economic Evaluation of Treatment for Postmenopausal Osteoporosis

    Nov 1, 2011, 00:00

  • NI3 Economic Evaluation in Niche Markets- The Role of the UK's Advisory Group for National Specialised Services for Rare Diseases and Disorders

    Nov 1, 2011, 00:00

  • PMD11 Treatment of Overactive Bladder and Fecal incontinence Patients from the Canary islands with Sacral Neuromodulation- Is It worth to Have regional Centers of Excellence?

    Nov 1, 2011, 00:00

  • PCV43 Budget Impact of the Implementation of a Treatment Protocol for Pulmonary Arterial Hypertension in A Referral Hospital

    Nov 1, 2011, 00:00

  • PSY41 Health Status and Health-Related Quality of Life Reported by Females with Bleeding Disorders from the Canadian National Haemophilia Registry

    Nov 1, 2011, 00:00

  • PRS41 Cost-Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis

    Nov 1, 2011, 00:00

  • PCN117 Health Resource Utilisation (HRU) Associated with Skeletal-Related Events (SREs) in Patients with Bone Metastases (BMS)- Results From a Retrospective, Multinational European Study

    Nov 1, 2011, 00:00

  • PRM63 Multiple Choices - How to Make Rational Decisions Across Several Interventions When Faced with Different Outcomes and Perspectives?

    Nov 1, 2011, 00:00

  • PUK16 Known-Group Validity of the Spanish Version of the Short-Form Overactive Bladder Health Related Quality of Life Questionnaire (OABQ-SF) in Subjects with Overactive Bladder

    Nov 1, 2011, 00:00

  • PHP41 Improving Use of Medicines in the Community Through Interventions

    Nov 1, 2011, 00:00

  • TP3 Patrones De Tratamiento Y Costos De atencion En Pacientes Con Artritis Reumatoide, Desde La perspectiva Del Proveedor De Servicios De Salud En México

    Nov 1, 2011, 00:00

  • PHP47 Evaluation of General Public'S Expenditure on Health Products

    Nov 1, 2011, 00:00

  • PMS54 The Clinical and Economic Burden of Poor Adherence with Osteoporosis Medications in Ireland

    Nov 1, 2011, 00:00

  • PSY10 Budget Impact Analysis of Somatuline Autogel in the Management of Acromegaly in Spain

    Nov 1, 2011, 00:00

  • PMD19 Cost-Effectiveness of Implantable Defibrillators after Myocardial Infarction Based on 8-Year Follow-up Data (MADIT II)

    Nov 1, 2011, 00:00

  • PDB12 Glargine Utilisation in Russia- A Prospective Study to Evaluate Patients Switched from NPH Insulin to Insulin Glargine Compared with Those Maintained on NPH

    Nov 1, 2011, 00:00

  • PRS6 Mortality Trends in Patients with Chronic Obstructive Pulmonary DISEASE- Data from a Structured Literature Review

    Nov 1, 2011, 00:00

  • PC3 Breast and Prostate Cancer Productivity Costs- A Comparison of the Human Capital Approach and Friction Cost Approach

    Nov 1, 2011, 00:00

  • PMH45 Comparison of the SF-6D and the EQ-5D in Patients with Schizophrenia

    Nov 1, 2011, 00:00

  • PHP33 Knowledge, Attitude, and Practices (KAP) of Food Practitioners on Hazard Analysis and Critical Control Point (HACCP) in the Kumasi Metropolis, Ghana

    Nov 1, 2011, 00:00

  • PIN4 Clinical and Economic Burden of Invasive Fungal Infection (IFI) in Europe- A Review of the Literature

    Nov 1, 2011, 00:00

  • PCV110 Health-Related Quality of Life After Venous Thromboembolism

    Nov 1, 2011, 00:00

  • PCN113 Cost-Utility Analysis of Combination Therapy of Pegylated Liposomal Doxorubicin(PLD) and Carboplatin for Korean Women with Platinum-Sensitive Ovarian Cancer

    Nov 1, 2011, 00:00

  • PHP127 Impact of Patient Access Schemes on NICE and SMC Guidance

    Nov 1, 2011, 00:00

  • PMD39 Cost Effectiveness Analysis of Intrathecal Baclofen Therapy (Tricumed™) Versus Medical Treatments for Severe Spasticity in Turkey

    Nov 1, 2011, 00:00

  • PMH16 Budgetary Impact Analysis of Buprenorphine/Naloxone (Suboxone®) in Opioid Maintenance Treatment in Spain

    Nov 1, 2011, 00:00

  • PRS50 The Dutch 1-Year Resource Use Results from the Experience Study, an International Registry of Real-World Outcomes for Asthma Patients Treated with Omalizumab

    Nov 1, 2011, 00:00

  • PRM9 What Guidance is Available for Budget Impact Analysis?

    Nov 1, 2011, 00:00

  • PIH47 Measuring the Burden of Disease and Injury in Spain Using Disability-Adjusted Life Years- A Population-Based Study

    Nov 1, 2011, 00:00

  • PRS30 Identifying the Patient Population Where Treatment of Severe Allergic Asthma with Omalizumab (XOLAIR®) Exhibits Optimal Cost-Effectiveness in Australia

    Nov 1, 2011, 00:00

  • PDB16 First Results of the Post-Marketing Survey of Vildagliptin in France

    Nov 1, 2011, 00:00

  • PHP86 Incorporating the Patient Perspective Into the Health Care Process- Experience from the C.A.T. Health System

    Nov 1, 2011, 00:00

  • PMH55 An Examination of Antidepressant-Related Sexual Dysfunction and Degree of Enjoyment and Satisfaction with Daily Activities, and Current Medication in Employed Patients

    Nov 1, 2011, 00:00

  • PIN110 Development of A Large Safety Database Using Studies Conducted During the Clinical Development and Post-Marketing of A Virosomal Aluminium-Free Hepatitis A Vaccine

    Nov 1, 2011, 00:00

  • PND68 Social Economic Burden and Health-Related Quality of Life in Patients with Rare Diseases in Europe (BURQOL-RD Project)- Methods of Selection of 10 Diseases for A European Survey

    Nov 1, 2011, 00:00

  • PMH8 US Government Initiatives for Supporting Comparative Effectiveness Research, An Example from Project Libra

    Nov 1, 2011, 00:00

  • PIH36 the Quality of Life of Patients with the Top 5 Diseases and the Way to Reflect the Burden of Diseases in Thailand- A Country-Wide Multicenter EQ-5D Measurement, 2010

    Nov 1, 2011, 00:00

  • QA1 Measuring the Benefits of Health Care- Dalys and Qalys – Does the Choice of Measure Matter? A Case Study

    Nov 1, 2011, 00:00

  • PMH3 Cost-Effectiveness Of Paliperidone Palmitate For The Treatment Of Schizophrenia In MÉxico

    Nov 1, 2011, 00:00

  • PHP23 Orphan Drug Access in Medicare Plans in the United States

    Nov 1, 2011, 00:00

  • PCN190 Use of Surrogate Measures of Survival in Economic Evaluations of Metastatic Breast Cancer Treatments

    Nov 1, 2011, 00:00

  • PRM3 Dimensionality Of Comorbidities In Heath Related Quality Of Life Comorbidity INDEX

    Nov 1, 2011, 00:00

  • PRM27 Modelling the Brazilian Extended Consumer Price Index for Pharmaceutical Products- Comparison Between Exponential Smoothing and Box-Jenkins Methods

    Nov 1, 2011, 00:00

  • PMS1 Tumor Necrosis Factor Alpha Inhibitors for the Treatment of Active Ankylosing Spondylitis

    Nov 1, 2011, 00:00

  • PDB1 Association Between Hypoglycemia and Medication Possession Ratio Among Veterans with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2011, 00:00

  • PIH45 Burden of Herpes Zoster and Post-Herpetic Neuralgia- Findings from a Cross-Sectional Patient Reported Outcomes Study

    Nov 1, 2011, 00:00

  • PRS24 Impact Of Age and Patient Co-Morbidities on Community Acquired Pneumonia (CAP) Related Costs at the Hospital Setting in a Well Defined Area Of Barcelona (Badalona, Spain)

    Nov 1, 2011, 00:00

  • PSS13 Economic Burden of Psoriasis and Diabetes in Patients With Psoriasis in the United States

    Nov 1, 2011, 00:00

  • PSY7 Cost Of Managing Bleeding-Related Episodes (BRE) For Romiplostim Versus Standard Of Care (SOC) In Patients With Chronic Immune Thrombocytopenia (ITP) In Mexico

    Nov 1, 2011, 00:00

  • PGI12 Gastroesophageal Reflux Disease Patients Who Switched from a Branded Proton Pump Inhibitor to a Generic One and Vice Versa- A Cost Comparison

    Nov 1, 2011, 00:00

  • PCN76 Cost-Effectiveness Analysis of Compliance with Clinical Practice Guidelines in Sarcoma Treatment- An Economic Evaluation in Two European Regions

    Nov 1, 2011, 00:00

  • PCN68 Cost-Effectiveness and Quality of Life Analysis of the Multicenter Itac02-01 Study- Prospective Randomized Comparison of Reduced Intensity Versus Non-Myeloablative Conditioning Regimen for Matched Related Allogeneic Stem Cell Transpla ...

    Nov 1, 2011, 00:00

  • PDB81 Assessment of Drug Adherence for Type 2 Diabetes Patients Using Vial or Pen Form Insulin- A Method to Adjust the Traditional Medication Possession Ratio

    Nov 1, 2011, 00:00

  • PCN75 Epidemiologic and Economic Impact of HPV (6/11/16/18) Vaccination in Turkey

    Nov 1, 2011, 00:00

  • PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome- Results from the Plato Study- A Canadian Analysis

    Nov 1, 2011, 00:00

  • PCN10 Comorbid Cardiovascular Diseases in Patients with Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • VA3 A Cost-Effectiveness Analysis of A 10-Valent Pneumococcal Conjugate Vaccine in Children in Six Latin American Countries

    Nov 1, 2011, 00:00

  • PND11 Budget Impact Analysis of First-Line Treatment for Relapsing – Remitting Multiple Sclerosis in Spain

    Nov 1, 2011, 00:00

  • PCN46 Cost of Metastatic Prostate Cancer Treatment in the 12 Months Following Diagnosis per Patient in Russian Federation

    Nov 1, 2011, 00:00

  • PRM67 What EPRO Modality is Appropriate for Your Study?

    Nov 1, 2011, 00:00

  • PSY51 Epidemiology and Treatment Patterns of inhibitor Hemophilia in Russia- Patient-reported Data

    Nov 1, 2011, 00:00

  • PCN66 A Cost and Outcomes Analysis of Bevacizumab plus Folfiri Versus Cetuximab Plus Folfiri for the Treatment of First-Line Metastatic Colorrectal Cancer Patients from the Brazilian Private Payer Perspective

    Nov 1, 2011, 00:00

  • PCN1 Burden of Hospitalization in Patients with Advanced Lung Cancer in France and Germany

    Nov 1, 2011, 00:00

  • PIN111 Dynamic Modeling of Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccination Against Streptococcus Pneumoniae in Taiwan

    Nov 1, 2011, 00:00

  • PHP4 The Appropriate Use of the Emergency Department for Paediatric Patients

    Nov 1, 2011, 00:00

  • PCN139 Human Papilloma Virus and Cervical Cancer - Knowledge and Interest of Man and Woman

    Nov 1, 2011, 00:00

  • QA3 Costo-Efectividad De Dabigatran Versus Warfarina En El Manejo De La Fibrilacion Auricular En Colombia

    Nov 1, 2011, 00:00

  • PSS8 Advanced Cutaneous Melanoma in the UK- A Systematic Review

    Nov 1, 2011, 00:00

  • PUK2 Comparative Effectiveness of Investigational Compound Ferumoxytol for the Treatment of Iron Deficiency Anaemia in Chronic Kidney Disease- Systematic Review and Mixed Treatment Comparison

    Nov 1, 2011, 00:00

  • PHP136 Radiology Diagnostics and Interventional Radiology Services Utilization Patterns and Economic Consequences Analysis in a Large Tertiary Care University Hospital – Three Year Trends

    Nov 1, 2011, 00:00

  • PMD29 A1CNow® as Ambulatory Monitoring of Glycated Hemoglobin in Diabetic Type 2 (DM2) Patients- Brazilian Economic Modeling

    Nov 1, 2011, 00:00

  • PCN42 Treatment Costs of Bone Metastases in Patients with Lung Cancer- Results From A French Prospective, Observational, Multicenter Study (GFPC 0601)

    Nov 1, 2011, 00:00

  • PHP167 Tell Me Who Your Friends are- “Peers” in Comparing Health Care Systems

    Nov 1, 2011, 00:00

  • PRS63 Faciliators and Barriers Associated with the Use of Pharmacological – Behavioral Combination Therapy to Smoking Cessation

    Nov 1, 2011, 00:00

  • PCN140 Rural - Urban Differences in Fatalistic Beliefs About Cancer Prevention

    Nov 1, 2011, 00:00

  • PHP18 Impacto De La Participacion Del Farmaceutico Como Parte Del Equipo De Salud En El Primer Nivel De atencion sobre Los Costos

    Nov 1, 2011, 00:00

  • PMD16 The Economic and Efficiency Gains associated with the Use of A Standardised, Automated BCR-ABL Monitoring Test (SBAT)- Results from A Budget Impact analysis for the USA

    Nov 1, 2011, 00:00

  • PCV92 Cost Utility of Ranolazine in the Symptomatic Treatment of Patients with Chronic Angina Pectoris in Spain

    Nov 1, 2011, 00:00

  • PMS43 Cost-Minimization Analysis of Collagenase Clostridium Histolyticum Compared with Fasciectomy in Patients with Dupuytren'S Contracture in Portugal

    Nov 1, 2011, 00:00

  • PHP48 Croatian Pharmaceutical Expenditure Before and After Healthcare Reform – Comparison to EU Countries

    Nov 1, 2011, 00:00

  • PCN168 Cost-Effectiveness Analysis of Different Cervical Cancer Prevention Approaches in the United States

    Nov 1, 2011, 00:00

  • MO2 Extrapolation in Oncology Modelling- Novel Methods for Novel Compounds

    Nov 1, 2011, 00:00

  • PIH68 Studying Heterogeneity in Treatment Response in Women with Idiopathic Menorrhagia Treated with Levonorgestrel-Releasing Intrauterine System (LNG-IUS)- Application of Innovative Methods to Identify Differential Response

    Nov 1, 2011, 00:00

  • PCN122 Disclosing Traditional CM) Use to the Health Care Providers- A Qualitative Study Among Cancer Patients at a Local Hospital in Malaysia

    Nov 1, 2011, 00:00

  • PHP7 Orphan Drugs for Rare Diseases in the European Union- Bridging the Gap between Drug Development and Unmet Medical Needs?

    Nov 1, 2011, 00:00

  • PRM7 Using Probabalistic Sensitivity Analysis in Budget Impact Models to Reduce Uncertainty and Improve Decision-Making

    Nov 1, 2011, 00:00

  • PHP27 Diffusion of Innovations in Health Care- Does the Dual Market Phenomenon Exist?

    Nov 1, 2011, 00:00

  • PMS7 Direct Treatment-Cost of Patients with Rheumatoid Arthritis in Medellin, Colombia

    Nov 1, 2011, 00:00

  • PMH1 Adjunctive Pharmacotherapy Among Initiators of SSRI Treatment for Major Depressive Disorder- A Cohort Study Using a UK Primary Care Database

    Nov 1, 2011, 00:00

  • PSS33 Estimation of Meaningful Change on the Skindex-29 and Dermatology Life Quality Index in Patients With Chronic Hand Eczema

    Nov 1, 2011, 00:00

  • PCV128 A Real World Evaluation to Describe the Characteristics, Outcomes and Resource Use Associated with Patients Being Managed by a Secondary Care Based Anticoagulation Service

    Nov 1, 2011, 00:00

  • PCN32 Cost Savings With Bevacizumab Compared to Sunitinib in the Treatment of MRCC

    Nov 1, 2011, 00:00

  • PHP139 Evolving PR Complexities are Affecting Launch Sequencing and Time to Market in 18 Developed and Emerging Markets

    Nov 1, 2011, 00:00

  • PMH9 Prescribing Patterns and Cost of Drugs for Alzheimer's Disease

    Nov 1, 2011, 00:00

  • PHP150 Pharmaceutical Pricing Under Uncertainty- Risk-Sharing Contracts

    Nov 1, 2011, 00:00

  • PRM29 Translation and Validation Study of Morisky Medication Adherence Scale (MMAS)- The Urdu Version

    Nov 1, 2011, 00:00

  • PCN195 Bayesian Calibration of A Cervical Cancer Model Using Markov Chain Monte Carlo

    Nov 1, 2011, 00:00

  • PMH60 Factors Associated with Health-Related Quality of Life in Alcohol Dependent Patients

    Nov 1, 2011, 00:00

  • PND55 The Predictors of Health-Related Quality of Life in Pediatric Epilepsy- A Systematic Review

    Nov 1, 2011, 00:00

  • PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil- A Real World Data Analysis

    Nov 1, 2011, 00:00

  • PCN45 Projection of the Patients' Population Treated for Chronic Myeloid Leukemia in Chronic Phase in Fran An Epidemiological Model at the Horizon 2015

    Nov 1, 2011, 00:00

  • PHP12 The Ratio of Public Reimbursement and Patients' Co-Payment in the Financing of Spa Services in Hungary

    Nov 1, 2011, 00:00

  • PIN47 Cost-Effectiveness of Telbivudine in First Line Treatment of HBEAG-Negative Patients with Chronic Hepatitis B (CHB) in the Turkish Healthcare Setting

    Nov 1, 2011, 00:00

  • PCV140 The Impact of National Mass Screening Program on Health Service Utilizations and Medical Expenses- In the Case of Hypertension Complications

    Nov 1, 2011, 00:00

  • PMS37 The Cost Effectiveness of Glucosamine Sulphate Powder (Glusartel) for the Treatment of Osteoarthritis of the Knee

    Nov 1, 2011, 00:00

  • PMH15 Mortality in relation to Disease Severity in Subjects with Dementia

    Nov 1, 2011, 00:00

  • PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy- Are Short-Term Increase in Costs Necessarily Bad?

    Nov 1, 2011, 00:00

  • PDB34 Medical Treatment Costs Attributable to Obesity in Diabetic Patients in the United States

    Nov 1, 2011, 00:00

  • PCV2 Estimated Cost of Acute Coronary Syndrome for 2011- Case of Mexico

    Nov 1, 2011, 00:00

  • PCN144 Health-Related Quality of Life in Prostate Cancer – One Year Follow-up and Comparison with General Population Norms

    Nov 1, 2011, 00:00

  • PMD48 An Economic Evaluation of the Heartware Ventricular assist Device in the NHS

    Nov 1, 2011, 00:00

  • PCV107 Correlation of Physician-Rated Adherence with Therapeutical Outcomes in Antihypertensive Treatment- Pooled Analysis Findings from Six Valsartan Studies Including 15,583 Available Patients

    Nov 1, 2011, 00:00

  • PHP163 Pharmaceutical Innovation- Definition, and Mechanisms for Reward

    Nov 1, 2011, 00:00

  • PIN19 Pharmacoeconomic Analysis of Pegylated Interferon Alfa Use in Chronic Hepatitis C

    Nov 1, 2011, 00:00

  • PCV120 Quality of Life in Chronic Symptomatic Heart Failure Patients in Spain, insight from the Inoescaro Study

    Nov 1, 2011, 00:00

  • PSU8 Risks and Benefits of Acrysof® Cachet™ Implantation in High Myopia (≥-6 DIOPTRE)- A Systematic Literature Review

    Nov 1, 2011, 00:00

  • PDB36 Estimating the Average Annual Cost of Treatment with Insulin for Patients with Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PCN62 Costs and Consequences of HPV Vaccination in Thailand- Results of a Prevalence Based Model

    Nov 1, 2011, 00:00

  • PIH64 Female Urinary Incontinence in Germany– Cost Explosion Tomorrow?

    Nov 1, 2011, 00:00

  • PCN132 A Development of Quality Indicators for Evaluating Home Palliative Care and Their Relation with Bereaved Family Satisfaction

    Nov 1, 2011, 00:00

  • PR1 Responsiveness of the Copd Assessment Test (CAT) Questionnaire During Exacerbations of COPD

    Nov 1, 2011, 00:00

  • PDB69 Prescription Pattern Study of Type 2 Diabetes Mellitus in Iran

    Nov 1, 2011, 00:00

  • PIH51 What Do Patients with Rare Diseases Experience in the Medical Encounter? Exploring Patient-Physician-Interaction Patterns, Its Antecedents and Its Consequences

    Nov 1, 2011, 00:00

  • PMD67 The Cost-Effectiveness of Transcatheter Aortic Valve Implantation in Elderly Patients with Severe Aortic Stenosis Who are Contraindicated for Conventional Surgical Aortic Valve replacement in the United Kingdom

    Nov 1, 2011, 00:00

  • PMS21 Differences in Cost-of-Illness and Quality of Life Between Rheumatoid Arthritis and Ankylosing Spondylitis in South Korea

    Nov 1, 2011, 00:00

  • PSY2 Coexistence of Immuno-Mediated Inflammatory Diseases- an Analysis of the Quebec Administrative Health Databases

    Nov 1, 2011, 00:00

  • PMH10 Exposure to Antipsychotic Medications During Four Year Periods Following Treatment Initiation among Children Under Six Years Old

    Nov 1, 2011, 00:00

  • PSY6 The Health Improvement Network (Thin) 2008-2009 Estimates of Psoriasis Incidence and Prevalence in Uk Primary Care

    Nov 1, 2011, 00:00

  • PCN116 Cost-Effectiveness of Denosumab Versus Zoledronic Acid (ZA) for the Prevention of Skeletal-related Events (SRE) in Patients with Bone Metastases from Solid Tumors in the Netherlands

    Nov 1, 2011, 00:00

  • PHP52 Inequalities in the Utilization of Home Hospice Services in Hungary

    Nov 1, 2011, 00:00

  • RS1 Literature Review On Patient Access Schemes, Flexible Pricing Schemes And Risk Sharing Agreements For Medicines

    Nov 1, 2011, 00:00

  • PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase- Five-Years Follow-up Simulated Cohort

    Nov 1, 2011, 00:00

  • PMH3 Olanzapine Long-Acting Injection for Schizophrenia- An Evaluation of Patient Functioning During 24 Weeks of Maintenance Therapy

    Nov 1, 2011, 00:00

  • PGI19 Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists or Sucralfate- A Cost-Effectiveness Analysis

    Nov 1, 2011, 00:00

  • PCV49 Evaluating the Management of the Rehabilitation Unit in A Tertiary Referral Hospital in Spain- A Cost-Analysis Study

    Nov 1, 2011, 00:00

  • PHP59 Estimation of Increases in Direct Medical Expenditures Associated with Medication Nonadherence and Potential Savings from Increased Adherence

    Nov 1, 2011, 00:00

  • PSU9 Incidence of Major Surgeries in Patients with Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PMS72 Assessment of Prior Use of Prescribed Pain Medications Among Elderly Patients Who Initiated Duloxetine

    Nov 1, 2011, 00:00

  • PMH61 A Descriptive Analysis of Atomoxetine Utilization in Attention Deficit/Hyperactivity Disorder (ADHD) the United Kingdom and Italy

    Nov 1, 2011, 00:00

  • PIN3 Pursuing Financial Sustainability To Fulfill The Millenium Development Goal Six In A Fragmented SYSTEM. The Experience Of The Universal Access To Antiretroviral Drugs In MÉxico 2007-2009

    Nov 1, 2011, 00:00

  • PDB50 Reduction in Comorbidities and Cost Savings Associated with Biochemical Control in Patients with Cushing's Disease- A Literature-Based Analysis

    Nov 1, 2011, 00:00

  • PHP6 Regional Variability in the Generic Antidepressant Market in Spain

    Nov 1, 2011, 00:00

  • PRS23 High Cost Cystic Fibrosis Patients as Identified in a Us Claims Database- A Closer Look at the Tail

    Nov 1, 2011, 00:00

  • PIN57 Cost-Effectiveness of the New Guidelines for the Prevention of Mother to Child Transmission of HIV in Uganda

    Nov 1, 2011, 00:00

  • PMS5 The Effect of one-Time Physical Therapy on Biochemical Markers of Bone Metabolism

    Nov 1, 2011, 00:00

  • PCN101 A Cost-Effectiveness Analysis for Second-Line Treatment of Relapsed/Refractory (RR) Multiple Myeloma (MM) in the United Kingdom

    Nov 1, 2011, 00:00

  • PDB10 Achieving Target Goals in Patients with T2DM Treated with Exenatide Once Weekly or Insulin Glargine- A Retrospective Analysis of the Number-Needed-To-Treat

    Nov 1, 2011, 00:00

  • PMS49 Cost-Effectiveness of Rituximab in the Treatment of RA Patients in the Netherlands

    Nov 1, 2011, 00:00

  • PSU24 Comparison of the Responsiveness of the SF-36 and the Raw and Rasch-Based Scores of the Oxford Knee Score in Patients Undergoing Total Knee Replacement

    Nov 1, 2011, 00:00

  • PCV127 Time to Initiation of Oral Antihyperglycaemic and Statin Therapy in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PHP5 Analysis of Linked Medical Claims Data for Preinvestigation in Modeling Studies

    Nov 1, 2011, 00:00

  • PCN107 Potential Benefits of Introducing A Companion Diagnostic in Advanced Non-Small Cell Lung Cancer

    Nov 1, 2011, 00:00

  • PHP50 The Valuation of End-of-Life Health Gains

    Nov 1, 2011, 00:00

  • PCN27 Budget Impact Analysis for Chronic Mieloid Leukemia Therapy in Bulgaria

    Nov 1, 2011, 00:00

  • PCN106 Capecitabine Plus Oxaliplatin (CAPOX) Versus Fluorouracil/Leucovorin plus Oxaliplatin (FOLFOX) in Stage III Colon Cancer- A Cost-Minimization Analysis Based on Real World Costs in the Netherlands

    Nov 1, 2011, 00:00

  • PMS46 Cost-Utility Analysis of Certolizumab Pegol versus Alternative Tumor Necrosis Factor-Inhibitors, for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Spain

    Nov 1, 2011, 00:00

  • PCV91 Cost-Effectiveness of Endovascular Treatment Versus Open Surgery in Patients with Steno-Occlusive Disease of the Femoral Artery

    Nov 1, 2011, 00:00

  • PCV30 Heart Failure (Re)Admissions in the Netherlands- Rates, Length of Stay and Costs

    Nov 1, 2011, 00:00

  • PRS39 Cost-Effectiveness of Roflumilast in Combination with Bronchodilator Therapies in Patients with Severe and Very Severe COPD in Switzerland

    Nov 1, 2011, 00:00

  • PMH44 Improving Health-Related Quality of Life for Patients with Refractory Post-Traumatic Stress Disorder- Use of Local Anesthetics Show Promise in a Clinical Case Series

    Nov 1, 2011, 00:00

  • PND27 Economic Analysis of Cost Per Episode of Care for Arm Spasticity and Cervical Dystonia- Comparison of Two Botulinum Toxin A Preparations in 20 Countries

    Nov 1, 2011, 00:00

  • PHP142 Landmark CER Study Methods Review

    Nov 1, 2011, 00:00

  • MO4 Outcomes Beyond Health

    Nov 1, 2011, 00:00

  • PHP144 Multi-Stakeholder Survey of Comparative Effectiveness Research Perceptions

    Nov 1, 2011, 00:00

  • PUK4 Comparing Projected Outcomes of Renal Transplant Recipients Based on Trial Endpoint of Renal Function and Receiving Different Immunosuppressive Regimens in the United States

    Nov 1, 2011, 00:00

  • PMD5 Diagnostic Accuracy of Clinical Characteristics following Minor Head injury- A Systematic review and Meta-analysis

    Nov 1, 2011, 00:00

  • PHP57 Centralized Drug Assessment in Catalonia- Where We Have Gone so Far?

    Nov 1, 2011, 00:00

  • PIN69 Methodological Challenges for Economic Evaluations of Vaccination Programs- The Case of Pertussis Booster Vaccination

    Nov 1, 2011, 00:00

  • PCN36 The Economic Impact of Treating Early Lung Cancer- A Systematic Review

    Nov 1, 2011, 00:00

  • PCN119 Lack of Data for Indirect Costs Associated With Treatment of Early Breast Cancer

    Nov 1, 2011, 00:00

  • PDB14 Assessment of the Clinical and Economic Benefits of Adequate Insulin Initiation and Intensification in People with Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PND3 Estimación Del proceso De procuración De órganos De Pacientes Con Muerte Cerebral En México 2009

    Nov 1, 2011, 00:00

  • PCN166 Public Accountability and Social Judgment in the Reimbursement Decision for Oncology Medications in Korea

    Nov 1, 2011, 00:00

  • PSY53 Changes in Concomitant therapy for Weight-related Illness Following Initiation of Weight Loss Pharmacotherapy

    Nov 1, 2011, 00:00

  • PDB30 Assessment of the Impact of the New Antidiabetic Treatment with Vildagliptin to Change the Total Costs on Diabetes Type 2

    Nov 1, 2011, 00:00

  • PMD21 The Clinical and Economic Benefits of Spinal Cord Stimulation in the Treatment of Failed Back Surgery Syndrome (Precise Study)

    Nov 1, 2011, 00:00

  • PMD15 Societal Costs of Routine Follow-up Services for Cardiac Implantable Electrical Devices in Germany and the United Kingdom - and the Impact of remote Monitoring

    Nov 1, 2011, 00:00

  • PRM16 Covariance Structures for Modeling Longitudinal Data

    Nov 1, 2011, 00:00

  • PCN53 Economic Burden of HPV-Related Head Neck and Anal Cancers in Germany

    Nov 1, 2011, 00:00

  • PRS12 A Budget Impact Analysis to Estimate the Economic Impact Of Beclomethasone/Formoterol for the Treatment of Moderate to Severe Persistent Asthma in Six Spanish Regions

    Nov 1, 2011, 00:00

  • PCN149 Health State Utility Values in Breast Cancer- A Review and Meta-Analysis

    Nov 1, 2011, 00:00

  • PHP152 The Administrative Burden of Patient Access Schemes in the Changing UK Health Care System- A Follow Up Study

    Nov 1, 2011, 00:00

  • PHP97 Use of Paediatric “Observation Status” and Effect on in-Patient Admission Rate in Accident and Emergency (AE) Departments

    Nov 1, 2011, 00:00

  • PUK9 Comparative Cost Analysis of Treatment for Renal Anemia with Methoxy Polyethylene-Glycol Erythropoietin Beta (MIRCERA®) Versus Erythropoietin Beta (NEORECORMON®)

    Nov 1, 2011, 00:00

  • PIN26 Economic and Health Related Quality of Life (HRQL) Comparison of Lopinavir/Ritonavir (LPV/R) and Atazanavir Plus Ritonavir (ATV+RTV)-Based Regimens for Antiretroviral (ARV) Experienced Brazilian Patients in 2011

    Nov 1, 2011, 00:00

  • PMS4 Efficacy and Effectiveness of Collagenase Clostridium Histolyticum for Dupuytren'S Contracture

    Nov 1, 2011, 00:00

  • PHP115 Preliminary Analysis of the Unwritten Decision Rules Behind the French Transparency Commission'S Assessment of Drugs

    Nov 1, 2011, 00:00

  • PCN114 Cost Effectiveness of Adjuvant Cyclophosphamide in the Treatment of Breast Cancer in Spain

    Nov 1, 2011, 00:00

  • PRS69 Socioeconomic Determinants of Smoking Status in Greece

    Nov 1, 2011, 00:00

  • PSU16 Minimally Invasive Surgery in Total Hip Arthroplasty- A Cost-Effectiveness Analysis

    Nov 1, 2011, 00:00

  • PRM33 Systematic Review of Health State Utilities in Spain

    Nov 1, 2011, 00:00

  • PDB17 Off-Label and Non-Licensed Endocrinology Medicine Use in Turkey- A Retrospective Analysis of Computer Records in the Turkish Ministry of Health

    Nov 1, 2011, 00:00

  • PCV11 Treatment and 12-Month Outcomes of Acute Coronary Syndromes Patients Aged 75 and ≥ 75 Years Undergoing Percutaneous Coronary Intervention- 14-Country Data on 4545 Patients from the Prospective Antiplatelet Treatment Outcomes Registry ...

    Nov 1, 2011, 00:00

  • PRM18 Sensitivity Analysis in Multi-Criteria Decision (MCDA) Models for Benefit-Risk Assessment

    Nov 1, 2011, 00:00

  • VI1 Determining the Impact of Modeling Additional Sources of Uncertainty in Value of Information Analysis

    Nov 1, 2011, 00:00

  • PHP83 The Economic Burden of Disease Related Malnutrition in Europe

    Nov 1, 2011, 00:00

  • PIH59 Are Older Mothers More prone to Having Children with Disabilities? Lifetime Disability Outcomes Versus Multiple Birth Reductions Arising from In-Vitro Fertilization (IVF) Treatments in Canada

    Nov 1, 2011, 00:00

  • PND32 Cost-Utility Analysis of Ropinirole in Parkinson'S Disease (PD) Treatment

    Nov 1, 2011, 00:00

  • PRS29 Evaluation of Stable COPD Medication Costs in Ukraine Based on GPS' Prescriptions Habits Survey Results

    Nov 1, 2011, 00:00

  • PHP169 The Values of General Practitioners/Family Physicians Should Be Fostered into Other Clinicians- A Research Study

    Nov 1, 2011, 00:00

  • PCN49 Incidence Rate and Burden of Illness Associated with Human Papillomavirus Related Genital Cancers in Spanish Women

    Nov 1, 2011, 00:00

  • PSY1 Tolerability of Oral Long-Acting Opioids in the Treatment of Chronic Pain- a Systematic Literature Review and Meta-Analysis

    Nov 1, 2011, 00:00

  • VI3 Sequential Treatment of Follicular Non-Hodgkin Lymphoma- Cost-Effectiveness and Value of information

    Nov 1, 2011, 00:00

  • PND63 Drug Prescription in and Hospitalization of Refractory Focal Epilepsy Patients in the German Neurotransdata (NTD) Neurologists' Network – is There An Unmet Need?

    Nov 1, 2011, 00:00

  • PSS4 Development of a Questionnaire Assessing the Burden of Ichthyosis in Infants

    Nov 1, 2011, 00:00

  • PSU21 Speech Problem and Health-Related Quality of Life in Head and Neck Cancer Survivors After Five Years of Treatments

    Nov 1, 2011, 00:00

  • PHP151 Evidence on the Impact of Managed Entries on Payers, Patients, Manufacturers, and Health Care Workers

    Nov 1, 2011, 00:00

  • PMD40 Cost Effectiveness of Fractional Flow reserve Measurement in Multivessel Coronary Artery Disease in Belgium and France

    Nov 1, 2011, 00:00

  • PMH51 Measuring Relapse After Substance Abuse Treatment- A Proportional Hazard Approach

    Nov 1, 2011, 00:00

  • VI4 the Value of information of A Multicentre Randomised Controlled Trial of intravenous Immunoglobulin for Sepsis (Severe Sepsis and Septic Shock)

    Nov 1, 2011, 00:00

  • PCV115 The Sensitivity of Pro's in Evaluating Adverse Events in People Receiving “Statin” Therapy

    Nov 1, 2011, 00:00

  • PMD36 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in the Netherlands

    Nov 1, 2011, 00:00

  • NI1 The UK Nice Single Technology Appraisal Process- A Qualitative Study Based on Manufacturers' Submissions

    Nov 1, 2011, 00:00

  • PDB8 A Network Meta Analysis to Compare Glycaemic Control in Patients with Type 2 Diabetes Treated with Exenatide Once Weekly or Liraglutide

    Nov 1, 2011, 00:00

  • PCN118 Consumption of Antineoplastic Agents in Slovak Republic Within Period of 2006-2010

    Nov 1, 2011, 00:00

  • PHP166 On-Going Market Access Advice A Possible solution to Help Ensure Long-Term Success in Post-Marketing Clinical Studies- Cross Functional Teams or External Consultation?

    Nov 1, 2011, 00:00

  • PMH38 Buprenorphine/Naloxone Versus Buprenorphine and Methadone in Heroin Addiction Detoxification- An Italian Cost-Utility Analysis

    Nov 1, 2011, 00:00

  • PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and Adolescents

    Nov 1, 2011, 00:00

  • PGI28 Disease-Specific Health-related Quality of Life in Patients with Quiescent Ulcerative Colitis- Effects of one Year Maintenance Treatment with MMX Mesalamine

    Nov 1, 2011, 00:00

  • PMD25 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk or Inoperable Patients with Symptomatic Aortic Valve Stenosis in Spain

    Nov 1, 2011, 00:00

  • RM4 Factores Predictores De Obstrucciones Coronarias Significativas En Pacientes Adultos Con CineangiocoronariografÍas Realizadas En Uruguay, Financiadas Por El Fondo Nacional De Recursos

    Nov 1, 2011, 00:00

  • PDB51 A Comparison of Insulin Adherence in Patients with Type 2 Diabetes Initiating Therapy with Insulin Detemir Flexpen® or NPH Insulin in a Vial

    Nov 1, 2011, 00:00

  • AD2 Cost-Consequence Analysis of Switching From An Oral Antipsychotic To Long Acting Injectable Risperidone Among Patients With Schizophrenia

    Nov 1, 2011, 00:00

  • PCN126 Which Factors Can Affect Utilities?

    Nov 1, 2011, 00:00

  • PMD64 The Effect of Supplementary Fees on the Diffusion of Medical Devices in the German System of Diagnosis related Groups (G-Drg)- The Case of Drug-Eluting Stents in Patients with Acute Myocardial Infarction

    Nov 1, 2011, 00:00

  • RS3 Evidence, Process or Context? Examining The Factors That Drive Coverage Decisions Of Pharmaceuticals By Health Technology Assessment Bodies In Europe

    Nov 1, 2011, 00:00

  • PMD49 The Potential Role of Magnetic Resonance Imaging (MRI) in Axillary Node Assessment of Early Breast Cancer- An Economic Evaluation

    Nov 1, 2011, 00:00

  • PHP3 A Review of Breast Cancer (BC) Care and Outcomes in Latin America Caribbean (LAC)

    Nov 1, 2011, 00:00

  • PCN19 The Broader Burden of HPV-related Disease in England- A Preliminary Analysis

    Nov 1, 2011, 00:00

  • MO1 Methods for Extrapolating Survival Data Used in NICE Technology Appraisals- Inconsistencies and Limitations

    Nov 1, 2011, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129 (current)
  • 130
  • »